Torthaí cuardaigh - Rodrigues, D N

Validation and utilisation of high-coverage next-generation sequencing to deliver the pharmacological audit trail de réir Ong, M, Carreira, S, Goodall, J, Mateo, J, Figueiredo, I, Rodrigues, D N, Perkins, G, Seed, G, Yap, T A, Attard, G, de Bono, J S

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Androgen receptor expression in circulating tumour cells from castration-resistant prostate cancer patients treated with novel endocrine agents de réir Crespo, M, van Dalum, G, Ferraldeschi, R, Zafeiriou, Z, Sideris, S, Lorente, D, Bianchini, D, Rodrigues, D N, Riisnaes, R, Miranda, S, Figueiredo, I, Flohr, P, Nowakowska, K, de Bono, J S, Terstappen, L W M M, Attard, G

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair de réir Shenoy, T. R., Boysen, G., Wang, M. Y., Xu, Q. Z., Guo, W., Koh, F. M., Wang, C., Zhang, L. Z., Wang, Y., Gil, V., Aziz, S., Christova, R., Rodrigues, D. N., Crespo, M., Rescigno, P., Tunariu, N., Riisnaes, R., Zafeiriou, Z., Flohr, P., Yuan, W., Knight, E., Swain, A., Ramalho-Santos, M., Xu, D. Y., de Bono, J., Wu, H.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán